- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Novel biomarkers and neuroimaging techniques in Parkinson’s disease ; volume:271 ; number:2 ; day:17 ; month:1 ; year:2024 ; pages:1056-1058 ; date:2.2024
Journal of neurology ; 271, Heft 2 (17.1.2024), 1056-1058, 2.2024
- Urheber
-
Saw, A.
Bari, S.
Robertson, Neil P.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00415-024-12187-6
- URN
-
urn:nbn:de:101:1-2024041316214078656760
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Saw, A.
- Bari, S.
- Robertson, Neil P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions
Fluid and Biopsy Based Biomarkers in Parkinson’s Disease
Transcriptomic imputation of genetic risk variants uncovers novel whole-blood biomarkers of Parkinson’s disease
Novel targeted therapies for Parkinson’s disease
Non-invasive electrophysiological biomarkers of aging and Parkinson’s disease
The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease
Novel gene (TMEM230) linked to Parkinson’s disease
Inflammatory microbes and genes as potential biomarkers of Parkinson’s disease
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
MRI biomarkers of freezing of gait development in Parkinson’s disease
Digital biomarkers for precision diagnosis and monitoring in Parkinson’s disease
COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015), a global –clinical evaluations, serum biomarkers, genetic studies and neuroimaging– prospective, multicenter, non-interventional, long-term study on Parkinson’s disease progression
Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions
Fluid and Biopsy Based Biomarkers in Parkinson’s Disease
Transcriptomic imputation of genetic risk variants uncovers novel whole-blood biomarkers of Parkinson’s disease
Novel targeted therapies for Parkinson’s disease
Non-invasive electrophysiological biomarkers of aging and Parkinson’s disease
The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease
Novel gene (TMEM230) linked to Parkinson’s disease
Inflammatory microbes and genes as potential biomarkers of Parkinson’s disease
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
MRI biomarkers of freezing of gait development in Parkinson’s disease
Digital biomarkers for precision diagnosis and monitoring in Parkinson’s disease
COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015), a global –clinical evaluations, serum biomarkers, genetic studies and neuroimaging– prospective, multicenter, non-interventional, long-term study on Parkinson’s disease progression
Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions
Fluid and Biopsy Based Biomarkers in Parkinson’s Disease
Transcriptomic imputation of genetic risk variants uncovers novel whole-blood biomarkers of Parkinson’s disease
Novel targeted therapies for Parkinson’s disease
Non-invasive electrophysiological biomarkers of aging and Parkinson’s disease
The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease
Novel gene (TMEM230) linked to Parkinson’s disease
Inflammatory microbes and genes as potential biomarkers of Parkinson’s disease
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
MRI biomarkers of freezing of gait development in Parkinson’s disease
Digital biomarkers for precision diagnosis and monitoring in Parkinson’s disease